RU2114846C1 - Дидезоксидидегидрокарбоциклические нуклеозиды, фармацевтическая композиция - Google Patents

Дидезоксидидегидрокарбоциклические нуклеозиды, фармацевтическая композиция Download PDF

Info

Publication number
RU2114846C1
RU2114846C1 RU92004364A RU92004364A RU2114846C1 RU 2114846 C1 RU2114846 C1 RU 2114846C1 RU 92004364 A RU92004364 A RU 92004364A RU 92004364 A RU92004364 A RU 92004364A RU 2114846 C1 RU2114846 C1 RU 2114846C1
Authority
RU
Russia
Prior art keywords
compound
compounds
purin
formula
pharmaceutically acceptable
Prior art date
Application number
RU92004364A
Other languages
English (en)
Russian (ru)
Other versions
RU92004364A (ru
Inventor
Бинс Роберт
Хьюа Мей
Лесли Майерс Питер
Сторер Ричард
Original Assignee
Риджентс Оф Дзе Юниверсити Оф Миннесота
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/146,252 external-priority patent/US4916224A/en
Priority claimed from GB888821011A external-priority patent/GB8821011D0/en
Priority claimed from US07/278,652 external-priority patent/US4931559A/en
Application filed by Риджентс Оф Дзе Юниверсити Оф Миннесота filed Critical Риджентс Оф Дзе Юниверсити Оф Миннесота
Publication of RU92004364A publication Critical patent/RU92004364A/ru
Application granted granted Critical
Publication of RU2114846C1 publication Critical patent/RU2114846C1/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
RU92004364A 1988-01-20 1989-01-19 Дидезоксидидегидрокарбоциклические нуклеозиды, фармацевтическая композиция RU2114846C1 (ru)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US07/146,252 US4916224A (en) 1988-01-20 1988-01-20 Dideoxycarbocyclic nucleosides
US146,252 1988-01-20
GB888821011A GB8821011D0 (en) 1988-09-07 1988-09-07 Chemical compounds
GB8821011,7 1988-09-07
GB8821011.7 1988-09-07
US278,652 1988-12-05
US07/278,652 US4931559A (en) 1988-01-20 1988-12-05 Optically-active isomers of dideoxycarbocyclic nucleosides

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU4613327 Division

Publications (2)

Publication Number Publication Date
RU92004364A RU92004364A (ru) 1996-09-20
RU2114846C1 true RU2114846C1 (ru) 1998-07-10

Family

ID=27264063

Family Applications (1)

Application Number Title Priority Date Filing Date
RU92004364A RU2114846C1 (ru) 1988-01-20 1989-01-19 Дидезоксидидегидрокарбоциклические нуклеозиды, фармацевтическая композиция

Country Status (29)

Country Link
JP (1) JP2793825B2 (zh)
KR (1) KR0127137B1 (zh)
AT (1) AT397801B (zh)
AU (2) AU626278B2 (zh)
BE (1) BE1003815A4 (zh)
CA (1) CA1339896C (zh)
CH (1) CH679152A5 (zh)
DE (1) DE3901502C2 (zh)
DK (1) DK175131B1 (zh)
ES (1) ES2010091A6 (zh)
FI (1) FI93546C (zh)
FR (1) FR2626002B1 (zh)
GB (1) GB2217320B (zh)
GR (1) GR890100033A (zh)
HU (1) HU203755B (zh)
IE (1) IE62275B1 (zh)
IL (1) IL88999A (zh)
IT (1) IT1229531B (zh)
LU (1) LU87437A1 (zh)
MY (1) MY103801A (zh)
NL (1) NL8900122A (zh)
NO (1) NO169123C (zh)
NZ (1) NZ227663A (zh)
OA (1) OA09031A (zh)
PL (1) PL163814B1 (zh)
PT (1) PT89482B (zh)
RU (1) RU2114846C1 (zh)
SE (1) SE505213C2 (zh)
YU (1) YU47791B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2593201C2 (ru) * 1998-12-04 2016-08-10 Астразенека Аб НОВЫЕ ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ ДЛЯ ПОЛУЧЕНИЯ ТРИАЗОЛО(4,5-d)ПИРИМИДИНА

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US4939252A (en) * 1989-04-20 1990-07-03 Hoffmann-La Roche Inc. Novel intermediates for the preparation of Carbovir
DK0479822T3 (da) * 1989-06-27 2000-03-20 Wellcome Found Terapeutiske nucleosider
GB8916478D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916479D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916477D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916480D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5144034A (en) * 1990-04-06 1992-09-01 Glaxo Inc. Process for the synthesis of cyclopentene derivatives of purines
US5241069A (en) * 1990-04-06 1993-08-31 Glaxo Inc. Carbonate intermediates for the synthesis of purine substituted cyclopentene derivatives
US5057630A (en) * 1990-04-06 1991-10-15 Glaxo Inc. Synthesis of cyclopentene derivatives
US5126452A (en) * 1990-04-06 1992-06-30 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
GB9108376D0 (en) * 1991-04-19 1991-06-05 Enzymatix Ltd Cyclopentenes
KR960705825A (ko) * 1993-11-12 1996-11-08 게리 디. 스트리트 면역억제제로서 유용한 6-옥소-뉴클레오시드(6-Oxo-nucleosides useful as immunosuppressants)
GB9721780D0 (en) * 1997-10-14 1997-12-10 Glaxo Group Ltd Process for the synthesis of chloropurine intermediates
AU1158000A (en) * 1998-10-30 2000-05-22 Lonza A.G. Method for producing 4- ((2',5'- diamino-6'- halopyrimidine- 4'-YL)amino)- cyclopent- 2-enylmethanols
US6433170B1 (en) 1998-10-30 2002-08-13 Lonza Group Method for producing 4-[2',5'-diamino-6'-halopyrimidine-4'-yl)amino]- cyclopent-2-enylmethanols
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
AR039540A1 (es) 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
CN112512529B (zh) 2018-07-27 2024-06-18 富士胶片株式会社 环戊烯嘌呤衍生物或其盐
WO2021191417A1 (en) 2020-03-27 2021-09-30 Som Innovation Biotech, S.A. Compounds for use in the treatment of synucleinopathies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268672A (en) * 1977-02-09 1981-05-19 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
JPS62177234A (ja) * 1986-01-30 1987-08-04 Mitsubishi Heavy Ind Ltd 遠心紡糸によるカ−ボン繊維の製造装置
IN164556B (zh) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1. Chemistry, biology and Medical Applications, R.T.Walker Plenum-Press, n-y, 1979, p.193. 2. EP, A, 0072027, C 07 D 473/16, 1983. 3. FR, A, 22 8289 2, A 61 K 31/52, 1976. 4. US, A, 4362729, C 07 D 239/70, 1982. *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2593201C2 (ru) * 1998-12-04 2016-08-10 Астразенека Аб НОВЫЕ ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ ДЛЯ ПОЛУЧЕНИЯ ТРИАЗОЛО(4,5-d)ПИРИМИДИНА
USRE46276E1 (en) 1998-12-04 2017-01-17 Astrazeneca Uk Limited Triazolo(4,5-D)pyrimidine compounds

Also Published As

Publication number Publication date
CA1339896C (en) 1998-06-02
DK175131B1 (da) 2004-06-14
IT1229531B (it) 1991-09-04
YU47791B (sr) 1996-01-09
IL88999A0 (en) 1989-08-15
ATA10689A (de) 1993-11-15
IT8947546A0 (it) 1989-01-19
PL163814B1 (en) 1994-05-31
NO890253D0 (no) 1989-01-19
NO890253L (no) 1989-07-21
BE1003815A4 (fr) 1992-06-23
PT89482A (pt) 1989-10-04
GR890100033A (el) 1994-03-31
GB2217320A (en) 1989-10-25
AU2867189A (en) 1989-07-20
CH679152A5 (zh) 1991-12-31
DK23489D0 (da) 1989-01-19
KR890011902A (ko) 1989-08-23
KR0127137B1 (ko) 1997-12-29
HUT48887A (en) 1989-07-28
MY103801A (en) 1993-09-30
DE3901502A1 (de) 1989-07-27
SE8900192D0 (sv) 1989-01-19
AU626278B2 (en) 1992-07-30
NO169123C (no) 1992-05-13
IE62275B1 (en) 1995-01-25
AU1018092A (en) 1992-03-12
OA09031A (en) 1991-03-31
FI890286A0 (fi) 1989-01-19
FI93546C (fi) 1995-04-25
AT397801B (de) 1994-07-25
YU12389A (en) 1991-10-31
JP2793825B2 (ja) 1998-09-03
LU87437A1 (fr) 1989-08-30
IL88999A (en) 1994-12-29
DE3901502C2 (de) 2002-06-13
GB8901187D0 (en) 1989-03-15
FR2626002A1 (fr) 1989-07-21
FR2626002B1 (fr) 1994-01-28
FI93546B (fi) 1995-01-13
HU203755B (en) 1991-09-30
GB2217320B (en) 1992-04-08
SE8900192L (sv) 1989-07-21
SE505213C2 (sv) 1997-07-14
JPH02196788A (ja) 1990-08-03
NL8900122A (nl) 1989-08-16
AU637015B2 (en) 1993-05-13
NO169123B (no) 1992-02-03
NZ227663A (en) 1990-09-26
PL277261A1 (en) 1989-09-18
DK23489A (da) 1989-07-21
FI890286A (fi) 1989-07-21
PT89482B (pt) 1994-02-28
IE890153L (en) 1989-07-20
ES2010091A6 (es) 1989-10-16

Similar Documents

Publication Publication Date Title
RU2114846C1 (ru) Дидезоксидидегидрокарбоциклические нуклеозиды, фармацевтическая композиция
RU2067097C1 (ru) Способ получения дидезоксидидегидрокарбоциклических нуклеозидов
US6534512B1 (en) Dideoxycarbocyclic nucleosides
US20080261973A1 (en) Sulphonamidoaniline Derivatives Being Janus Kinase Inhibitors
JPH11139976A (ja) 治療用ヌクレオシド類
US20150166546A1 (en) Pyrazolo[1,5-a]pyrimidines as antiviral agents
US5122517A (en) Antiviral combination comprising nucleoside analogs
CZ658390A3 (en) Enantiomeric purine derivatives, process of their preparation, pharmaceutical compositions containing thereof and their use
AU2023270323A1 (en) Antiviral compounds
EP0630242B1 (en) Further indole derivatives with antiviral activity
EP0346132B1 (en) Pharmaceutical products
US4950758A (en) Optically-active isomers of dideoxycarbocyclic nucleosides
US4931559A (en) Optically-active isomers of dideoxycarbocyclic nucleosides
EP0366385A1 (en) Guanine derivatives having antiviral activity and their pharmaceutically acceptable salts
US5567703A (en) Method for treating HIV infections with dideoxycarbocyclic nucleosides
US5175292A (en) Intermediates for the preparation of dideoxycarbocyclic nucleosides
GB2243609A (en) Carbocyclic nucleosides
SI8910123A (sl) Dideoksidihidrokarbocikličninukleozidi
CN1031055C (zh) 二脱氧二脱氢碳环核苷的制备方法
HU211577A9 (hu) Terápiás nukleozidok Az átmeneti oltalom az 1 -20. igénypontokra vonatkozik.